Polyskin Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 1.73 Cr
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -40.44%
- Profit Growth -38.36%
- Net Worth -0.35%
- Total Assets 3.45%
About Polyskin Life Sciences India
Polyskin Life Sciences India Private Limited (PLSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 July 2011 and has a history of 13 years and six months. Its registered office is in Thiruvananthapuram, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Haja Maheen and Sthuthi Mohan serve as directors at the Company.
Company Details
-
Location
Thiruvananthapuram, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100KL2011PTC028838
-
Company No.
028838
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jul 2011
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Polyskin Life Sciences India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haja Maheen
|
Managing Director | 11-Jul-2011 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sthuthi Mohan
|
Director | 25-Apr-2022 | Current |
Financial Performance of Polyskin Life Sciences India.
Polyskin Life Sciences India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 40.44% decrease. The company also saw a substantial fall in profitability, with a 38.36% decrease in profit. The company's net worth dipped by a decrease of 0.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Polyskin Life Sciences India?
Unlock access to Polyskin Life Sciences India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Prana Bio Reactor Systems Private LimitedHaja Maheen is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Polyskin Life Sciences India?
Unlock and access historical data on people associated with Polyskin Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polyskin Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polyskin Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
